# OnCo record paper-raymond-sunitinib-pnet-nejm-2011 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-raymond-sunitinib-pnet-nejm-2011/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-raymond-sunitinib-pnet-nejm-2011" ;
  schema:name "Sunitinib malate for the treatment of pancreatic neuroendocrine tumours"@en ;
  schema:description "The multikinase inhibitor sunitinib doubled the time to progression in advanced pancreatic neuroendocrine tumours and was approved at the same time as everolimus, giving the disease its first targeted therapies."@en ;
  schema:url <https://onco.cc/key-papers/paper-raymond-sunitinib-pnet-nejm-2011/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1003825>, <https://pubmed.ncbi.nlm.nih.gov/21306237/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1003825> ;
  schema:datePublished "2011"^^xsd:gYear ;
  schema:author "Raymond E, Dahan L, Raoul JL, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic-net/> ;
  onco:drugs <https://onco.cc/drugs/sunitinib/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
